CANY
PRVB

Caxton Associates (New York)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Caxton Associates (New York)’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,198
Closed -$119K – 729
2021
Q4 		$119K Buy
+21,198
New +$119K 0.01% 492